Overview |
bs-3697R |
CTR9 Polyclonal Antibody |
WB, ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC) |
Human |
Mouse, Rat, Dog, Cow, Sheep, Pig, Horse, Chicken |
Specifications |
Unconjugated |
Rabbit |
KLH conjugated synthetic peptide derived from human CTR9 |
751-850/1173 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
Target |
9646 |
Nucleus |
SH2BP1; TSBP; Ctr 9; Ctr9; Ctr9 Paf1/RNA polymerase II complex component, homolog; p150; RNA polymerase associated protein CTR9 homolog; SH2 binding phosphoprotein; SH2 domain binding protein 1 tetratricopeptide repeat containing; TPR containing SH2 binding phosphoprotein; Paf1/RNA polymerase II complex component homolog Ctr9; SH2 domain binding protein 1; CTR9_HUMAN. |
CTR9 is a component of the PAF (polymerase-associated factor) complex which interacts with histone-modifying enzymes and RNA polymerase II and plays a role in a number of transcription-related processes. Recent studies show that CTR9 can regulate IL-6-responsive gene transcription by influencing histone methylation. |
Application Dilution |
WB |
1:300-5000 |
ELISA |
1:500-1000 |
IHC-P |
1:200-400 |
IHC-F |
1:100-500 |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |